QTc Assessment in a Single-Dose Study of Hydronidone Capsules

Clinical trial NCT07263152 · COMPLETED

Trial details

NCT number: NCT07263152
Sponsor: Beijing Continent Pharmaceutical Co, Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Fibrosis

Start date: 2025-12-30
Primary completion: 2026-02-09
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.